BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Muñoz M, Gómez-Ramírez S, García-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009; 15(37): 4666-4674 [PMID: 19787830 DOI: 10.3748/wjg.15.4666]
URL: https://www.wjgnet.com/2220-6124/full/v15/i37/4666.htm
Number Citing Articles
1
Aditi Kumar, Matthew J. Brookes. Iron Therapy in Inflammatory Bowel DiseaseNutrients 2020; 12(11): 3478 doi: 10.3390/nu12113478
2
Michael Auerbach, Harold Ballard. Clinical Use of Intravenous Iron: Administration, Efficacy, and SafetyHematology 2010; 2010(1): 338 doi: 10.1182/asheducation-2010.1.338
3
Bhavesh S. Barot, Punit B. Parejiya, Pragna K. Shelat, Gaurang B. Shah, Dharmik M. Mehta, Trupti V. Pathak. Physicochemical and toxicological characterization of sucrose-bound polynuclear iron oxyhydroxide formulationsJournal of Pharmaceutical Investigation 2015; 45(1): 35 doi: 10.1007/s40005-014-0143-2
4
Rahul P Patel, Troy Wanandy, Serena Loring, Cameron Johns, Joseph Hutchinson, Madhur Shastri. Stability of Diluted Iron Polymaltose in PVC Infusion BagsJournal of Pharmacy Practice and Research 2013; 43(2): 112 doi: 10.1002/j.2055-2335.2013.tb00232.x
5
Walter Reinisch, Michael Staun, Sunil Bhandari, Manuel Muñoz. State of the iron: How to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel diseaseJournal of Crohn's and Colitis 2013; 7(6): 429 doi: 10.1016/j.crohns.2012.07.031
6
Kyeong Ok Kim. Management of Anemia in Patients with Inflammatory Bowel DiseaseThe Korean Journal of Gastroenterology 2015; 65(3): 145 doi: 10.4166/kjg.2015.65.3.145
7
RODOLFO D. CANÇADO, MANUEL MUÑOZ. Iron replacement options: oral and intravenous formulationsTransfusion Alternatives in Transfusion Medicine 2012; 12(3-4): 103 doi: 10.1111/j.1778-428X.2012.01178.x
8
Elpis Mantadakis. Advances in Pediatric Intravenous Iron TherapyPediatric Blood & Cancer 2016; 63(1): 11 doi: 10.1002/pbc.25752
9
Fernando Gomollón, Javier P. Gisbert, José Antonio García-Erce. Intravenous iron in digestive diseases: a clinical (re)viewTherapeutic Advances in Chronic Disease 2010; 1(2): 67 doi: 10.1177/2040622310373675
10
Fermín Mearin, Agustín Balboa, Antoni Castells, J. Enrique Domínguez, Maria Esteve, Jose A. García-Erce, Javier Pérez Gisbert, Fernando Gomollón, Julián Panés, Julio Ponce. Anemia ferropénica y uso de hierro endovenoso en patología digestivaGastroenterología y Hepatología 2010; 33(8): 605 doi: 10.1016/j.gastrohep.2010.08.001
11
M. A. Abounassif, M. A. Al‐Omar, A.‐G. E. Amr, G. A. E. Mostafa. PVC membrane sensor for potentiometric determination of iron (II) in some pharmaceutical formulations based on a new neutral ionophoreDrug Testing and Analysis 2011; 3(6): 373 doi: 10.1002/dta.231
12
Cem Çekiç, Serkan İpek, Fatih Aslan, Zehra Akpınar, Mahmut Arabul, Firdevs Topal, Elif Sarıtaş Yüksel, Emrah Alper, Belkıs Ünsal. The Effect of Intravenous Iron Treatment on Quality of Life in Inflammatory Bowel Disease Patients with Nonanemic Iron DeficiencyGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/582163
13
Role of intravenous iron therapy for management of perioperative anaemia: A narrative reviewPerioperative Precision Medicine 2024;  doi: 10.61189/956852bomilz
14
Walter Reinisch, Istvan Altorjay, Ferenc Zsigmond, Christian Primas, Harald Vogelsang, Gottfried Novacek, Sieglinde Reinisch, Lars L. Thomsen. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2015; 50(10): 1226 doi: 10.3109/00365521.2015.1031168
15
W. Reinisch, Y. Chowers, S. Danese, A. Dignass, F. Gomollón, O. Haagen Nielsen, P. L. Lakatos, C. W. Lees, S. Lindgren, M. Lukas, G. J. Mantzaris, P. Michetti, B. Moum, L. Peyrin-Biroulet, M. Toruner, J. van der Woude, G. Weiss, H. Stoevelaar. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness methodAlimentary Pharmacology & Therapeutics 2013; 38(9): 1109 doi: 10.1111/apt.12493
16
Kevin T. Lynch, Taryn E. Hassinger. Preoperative Identification and Management of Anemia in the Colorectal Surgery PatientClinics in Colon and Rectal Surgery 2023; 36(03): 161 doi: 10.1055/s-0043-1760868
17
Eboselume Akhuemonkhan, Alyssa Parian, Kathryn A Carson, Susan Hutfless. Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010–2014Inflammatory Bowel Diseases 2018; 24(8): 1801 doi: 10.1093/ibd/izy063
18
Markus R. Jahn, Hans B. Andreasen, Sören Fütterer, Thomas Nawroth, Volker Schünemann, Ute Kolb, Wolfgang Hofmeister, Manuel Muñoz, Klaus Bock, Morten Meldal, Peter Langguth. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implicationsEuropean Journal of Pharmaceutics and Biopharmaceutics 2011; 78(3): 480 doi: 10.1016/j.ejpb.2011.03.016
19
Ana Isabel Lopes, Sara Azevedo. Current Topics in Anemia2018;  doi: 10.5772/intechopen.69203
20
Angelina Dosal, Xavier Calvet, Laura Moreno, María López, Ariadna Figuerola, Miquel Ángel Ruíz, David Suárez, Emili Gené, Mireia Miquel, Albert Villoria. Uso del hierro intravenoso en un hospital de día de aparato digestivo: indicaciones, dosificación y efectos adversosGastroenterología y Hepatología 2010; 33(7): 479 doi: 10.1016/j.gastrohep.2010.02.011
21
FERNANDO GOMOLLÓN, JAVIER P. GISBERT. Intravenous iron in digestive diseasesTransfusion Alternatives in Transfusion Medicine 2012; 12(3-4): 122 doi: 10.1111/j.1778-428X.2012.01170.x
22
Lucia Cococcioni, Licia Pensabene, Sara El-Khouly, Sibongile Chadokufa, Sara McCartney, Efstratios Saliakellis, Fevronia Kiparissi, Osvaldo Borrelli. Ferric carboxymaltose treatment for iron deficiency anemia in children with inflammatory bowel disease: Efficacy and risk of hypophosphatemiaDigestive and Liver Disease 2021; 53(7): 830 doi: 10.1016/j.dld.2021.02.017
23
Agustín Urrutia, Emilio Sacanella, Jordi Mascaro, Francesc Formiga. Anemia en el ancianoRevista Española de Geriatría y Gerontología 2010; 45(5): 291 doi: 10.1016/j.regg.2010.06.003
24
Anthony E. Wiskin, Ben J. Fleming, Stephen A. Wootton, R. Mark Beattie. Anaemia and iron deficiency in children with inflammatory bowel diseaseJournal of Crohn's and Colitis 2012; 6(6): 687 doi: 10.1016/j.crohns.2011.12.001
25
Chen Yueying, Wang Yu Fan, Shen Jun. Anemia and iron deficiency in Crohn’s diseaseExpert Review of Gastroenterology & Hepatology 2020; 14(3): 155 doi: 10.1080/17474124.2020.1732817
26
E. O. Kurilovich, O. I. Volkova, L. D. Popovich. Clinical and economic aspects of the use of parenteral iron preparations for the correction of iron deficiency and anemia in surgical patientsGlavvrač (Chief Medical Officer) 2020; (12): 44 doi: 10.33920/med-03-2012-04
27
G. Barragán-Ibañez, A. Santoyo-Sánchez, C.O. Ramos-Peñafiel. Iron deficiency anaemiaRevista Médica del Hospital General de México 2016; 79(2): 88 doi: 10.1016/j.hgmx.2015.06.008
28
Yash Shah, Dhruvan Patel, Nabeel Khan. Iron deficiency anemia in IBD: an overlooked comorbidityExpert Review of Gastroenterology & Hepatology 2021; 15(7): 771 doi: 10.1080/17474124.2021.1900730
29
Hee-Sun Park, Tae-Yop Kim, Ha-Jung Kim, Young-Jin Ro, Hwa-Young Jang, Won Uk Koh. The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized TrialJournal of Clinical Medicine 2019; 8(10): 1674 doi: 10.3390/jcm8101674
30
Stefano de Biase, Giovanni Merlino, Simone Lorenzut, Mariarosaria Valente, Gian Luigi Gigli. ADMET considerations for restless leg syndrome drug treatmentsExpert Opinion on Drug Metabolism & Toxicology 2012; 8(10): 1247 doi: 10.1517/17425255.2012.708023
31
Reeta Mahey, Alka Kriplani, Krishna D. Mogili, Neerja Bhatla, Garima Kachhawa, Renu Saxena. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleedingInternational Journal of Gynecology & Obstetrics 2016; 133(1): 43 doi: 10.1016/j.ijgo.2015.09.007
32
Dorothea Niepel, Thomas Klag, Nisar P. Malek, Jan Wehkamp. Practical guidance for the management of iron deficiency in patients with inflammatory bowel diseaseTherapeutic Advances in Gastroenterology 2018; 11: 175628481876907 doi: 10.1177/1756284818769074
33
Guy Rostoker, Nosratola D. Vaziri. Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populationsHeliyon 2019; 5(7): e02045 doi: 10.1016/j.heliyon.2019.e02045
34
José Antonio García-Erce, Manuel Quintana Díaz, Manuel Muñoz Gómez. Transfusión y anticoagulación en el manejo de la hemorragia digestiva alta no varicosa en EspañaGastroenterología y Hepatología 2013; 36(2): 115 doi: 10.1016/j.gastrohep.2012.09.004
35
Sanghoon Lee, Ki‐Jin Ryu, Eun Sil Lee, Keun Ho Lee, Jeong Jae Lee, Tak Kim. Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open‐label, multicenter, randomized studyJournal of Obstetrics and Gynaecology Research 2019; 45(4): 858 doi: 10.1111/jog.13893
36
Rayan Bou-Fakhredin, Racha Halawi, Joseph Roumi, Ali Taher. Insights into the diagnosis and management of iron deficiency in inflammatory bowel diseaseExpert Review of Hematology 2017; 10(9): 801 doi: 10.1080/17474086.2017.1355233
37
S. Bhandari. Beyond efficacy and safety--the need for convenient and cost-effective iron therapy in health careClinical Kidney Journal 2011; 4(suppl 1): i14 doi: 10.1093/ndtplus/sfr044
38
João Ricardo Friedrisch, Rodolfo Delfini Cançado. Intravenous ferric carboxymaltose for the treatment of iron deficiency anemiaRevista Brasileira de Hematologia e Hemoterapia 2015; 37(6): 400 doi: 10.1016/j.bjhh.2015.08.012
39
Mirela Țigliș, Tiberiu Paul Neagu, Andrei Niculae, Ioan Lascăr, Ioana Marina Grințescu. Incidence of Iron Deficiency and the Role of Intravenous Iron Use in Perioperative PeriodsMedicina 2020; 56(10): 528 doi: 10.3390/medicina56100528